AAAAAA

   
Results: 1-7 |
Results: 7
Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: Two common founder mutations of BRCA1 in Japanese population
Authors: Sekine, M Nagata, H Tsuji, S Hirai, Y Fujimoto, S Hatae, M Kobayashi, I Fujii, T Nagata, I Ushijima, K Obata, K Suzuki, M Yoshinaga, M Umesaki, N Satoh, S Enomoto, T Motoyama, S Tanaka, K
Citation: M. Sekine et al., Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: Two common founder mutations of BRCA1 in Japanese population, CLIN CANC R, 7(10), 2001, pp. 3144-3150
Prognostic value of thymidine phosphorylase immunostaining in patients with uterine cervical cancer treated concurrently with doxifluridine, radiotherapy and immunotherapy
Authors: Sato, S Yajima, A Sasaki, H Mizutani, K Honjo, H Yamamoto, K Ozaki, M Hasegawa, K Kudo, T Yakushiji, M Hatae, M Noda, K
Citation: S. Sato et al., Prognostic value of thymidine phosphorylase immunostaining in patients with uterine cervical cancer treated concurrently with doxifluridine, radiotherapy and immunotherapy, ONCOL REP, 8(2), 2001, pp. 239-244
Effects of concomitant use of doxifluridine, radiotherapy and immunotherapy in patients with advanced cervical cancer
Authors: Yamamoto, K Noda, K Hatae, M Kudo, T Hasegawa, K Nishimura, R Honjo, H Yajima, A Sato, S Mizutani, K Yakushiji, M Terashima, Y Ochiai, K Sasaki, H Ozaki, M
Citation: K. Yamamoto et al., Effects of concomitant use of doxifluridine, radiotherapy and immunotherapy in patients with advanced cervical cancer, ONCOL REP, 8(2), 2001, pp. 273-277
Localization of a novel susceptibility gene for familial ovarian cancer tochromosome 3p22-p25
Authors: Sekine, M Nagata, H Tsuji, S Hirai, Y Fujimoto, S Hatae, M Kobayashi, I Fujii, T Nagata, I Ushijima, K Obata, K Suzuki, M Yoshinaga, M Umesaki, N Satoh, S Enomoto, T Motoyama, S Tanaka, K
Citation: M. Sekine et al., Localization of a novel susceptibility gene for familial ovarian cancer tochromosome 3p22-p25, HUM MOL GEN, 10(13), 2001, pp. 1421-1429
Intrauterine infection, magnesium sulfate exposure and cerebral palsy in infants born between 26 and 30 weeks of gestation
Authors: Matsuda, Y Kouno, S Hiroyama, Y Kuraya, K Kamitomo, M Ibara, S Hatae, M
Citation: Y. Matsuda et al., Intrauterine infection, magnesium sulfate exposure and cerebral palsy in infants born between 26 and 30 weeks of gestation, EUR J OB GY, 91(2), 2000, pp. 159-164
Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer
Authors: Sugiyama, T Yakushiji, M Noda, K Ikeda, M Kudoh, R Yajima, A Tomoda, Y Terashima, Y Takeuchi, S Hiura, M Saji, F Takahashi, T Umesaki, N Sato, S Hatae, M Ohashi, Y
Citation: T. Sugiyama et al., Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer, ONCOL-BASEL, 58(1), 2000, pp. 31-37
Hemangioma of the umbilical cord: Stenotic change of the umbilical vessels
Authors: Kamitomo, M Sueyoshi, K Matsukita, S Matsuda, Y Hatae, M Ikenoue, T
Citation: M. Kamitomo et al., Hemangioma of the umbilical cord: Stenotic change of the umbilical vessels, FETAL DIAGN, 14(6), 1999, pp. 328-331
Risultati: 1-7 |